Medications for Idiopathic Neutropenia

2 results
  • neupogen - filgrastim injection, solution

    (Filgrastim)
    Amgen, Inc
    NEUPOGEN is a leukocyte growth factor used to reduce infection risk and neutropenia in cancer patients on chemotherapy or bone marrow transplant, treat AML-related neutropenia, mobilize stem cells for collection, manage severe chronic neutropenia, and improve survival after myelosuppressive radiation exposure.
  • nivestym - filgrastim - aafi injection, solution

    (Filgrastim-Aafi)
    Pfizer Laboratories Div Pfizer Inc
    Nivestym is a leukocyte growth factor indicated to reduce febrile neutropenia in nonmyeloid malignancy patients on myelosuppressive chemotherapy, shorten neutrophil recovery in AML, reduce neutropenia after bone marrow transplantation, mobilize progenitor cells for leukapheresis, and treat severe chronic neutropenia (congenital, cyclic, or idiopathic).